| Literature DB >> 25006207 |
Sebastiaan Mastenbroek1, Sjoerd Repping2.
Abstract
All agree that in hindsight the rapid adoption of preimplantation genetic screening (PGS) using cleavage stage biopsy and fluorescence in situ hybridization (FISH) in routine clinical practice without proper evaluation of (cost-)effectiveness basically resulted in couples paying more money for a less effective treatment. Now, almost 20 years later, we are on the verge of a new era of PGS. But have things really changed or are we simply going back to the future?Entities:
Keywords: IVF/ICSI; PGS; aneuploidy; efficacy; randomized controlled trials
Mesh:
Year: 2014 PMID: 25006207 DOI: 10.1093/humrep/deu163
Source DB: PubMed Journal: Hum Reprod ISSN: 0268-1161 Impact factor: 6.918